Agile Therapeutics Inc., of Princeton, N.J., nominated Sharon Barbari for election to its board.
Biosig Technologies Inc., of Westport, Conn., appointed Anthony Zook to the board of its majority-owned subsidiary, Viralclear Pharmaceuticals, Inc.
Clearside Biomedical Inc., of Alpharetta, Ga., appointed Nancy J. Hutson to its board.
Emergent Biosolutions Inc., of Gaithersburg, Md., appointed Karen L. Smith chief medical officer.
Imago Biosciences Inc., of San Francisco, appointed Bob Baltera to its board.
Moleculin Biotech Inc., of Houston, appointed Richard Whitley to its science advisory board.
Morphosys AG, of Planegg, Germany, appointed Roland Wandeler chief commercial officer.
Rocket Pharmaceuticals Inc., of New York, appointed Elisabeth Bjӧrk to its board.
Silverback Therapeutics Inc., of Seattle, appointed Laura Shawver president, CEO and director.
Therapeuticsmd Inc., of Boca Raton, Fla., appointed Karen L. Ling to its board.
Trovagene Inc., of San Diego, appointed James Armitage, Lâle White and Gary Pace to its board.